期刊文献+

多重耐药鲍曼不动杆菌感染相关影响因素分析 被引量:8

下载PDF
导出
摘要 目的了解綦江区人民医院多重耐药鲍曼不动杆菌感染现况,并对多重耐药鲍曼不动杆菌感染相关影响因素进行调查分析。方法选择2011年7月至2013年6月綦江区人民医院重症医学科鲍曼不动杆菌感染患者作为研究对象,收集其病例资料和相关影响因素资料。结果綦江区人民医院重症医学科多重耐药鲍曼不动杆菌医院感染率为1.94%,多重耐药鲍曼不动杆菌平均住院天数和平均呼吸机治疗天数[(41.74±46.16)d和(16.32±14.13)d]均大于鲍曼不动杆菌[(29.35±26.05)d和(9.24±8.27)d],差异有统计学意义(P<0.05);住院期间手消毒液每日使用量进行比较,鲍曼不动杆菌感染患者[(37.17±11.48)mL]要大于多重耐药鲍曼不动杆菌感染患者[(22.26±8.92)mL],差异有统计学意义(P<0.05);多重耐药鲍曼不动杆菌感染患者抗菌药物使用不规范率要高于鲍曼不动杆菌感染患者,差异有统计学意义(χ2=8.499,P<0.05)。结论加强手卫生管理、规范抗菌药物使用对降低多重耐药鲍曼不动杆菌感染和预防医院感染暴发流行具有重要意义。
出处 《检验医学与临床》 CAS 2014年第14期1958-1959,1961,共3页 Laboratory Medicine and Clinic
基金 重庆市卫生局重点项目(2012-1-108)
  • 相关文献

参考文献9

  • 1杨慧,向平超,郭伟安,孙佳,宋丽萍,张硕.RICU多重耐药菌的耐药及危险因素分析[J].中国呼吸与危重监护杂志,2010,9(1):19-22. 被引量:112
  • 2Peleg AY, Seifert H, Paterson DL. Acinetobacter bauman- nii: emergence of a successful pathogen[J]. Clin Microbiol Rev, 2008,21 (3) : 538-582.
  • 3Zhou H, Yang Q, Yu YS, et al. Clonal spread of imipenem-re- sistant acinetobacter baumannii among different cities of Chi- na[J]. J Clin Micrubiol, 2007,45 (12) : 4054-4057.
  • 4Perez F, Hujer AM, Hujer KM,et al. Global challenge of multidrug-resistant Acinetobacter baumannii[J]. Antimi- crob Agents Chemother, 2007,51 (10) : 3471-3484.
  • 5Daniel J, Rogawski E, Kerri A, et al. Transfer of multidrug- resistant bacteria to healthcare workers' gloves and gowns af- ter patient contact increases with environmental contamina- tion[J]. Crit Care Med,2012,40(4) : 1045-1051.
  • 6Daniel J, Stephen Y, Catherine L, et al. Frequent multi- drug-resistant acinetobacter baumannii contamination of gloves,gowns,and hands of healthcare workers[J]. Infect Control Hosp Epidemiol, 2010,31(7) : 716-721.
  • 7Munoz-Price LS, Weinstein RA. Acinetobacter infection [J]. N Engl J Med,2008,358(12):1271-1281.
  • 8刘丁,陈萍,陈伟,俞志海,练向群.鲍曼不动杆菌医院感染的危险因素及基因分型研究[J].中华流行病学杂志,2003,24(2):140-142. 被引量:71
  • 9Aloush V, Navon VS, Seigman LY,et al. Multi drug-re- sistant Pseudomonas Aerugmosa: risk factors and clinical impact[J]. Antimierob Agents Chemother, 2006,50 (8) : 43-48.

二级参考文献21

  • 1俞森洋.常见感染致病菌的耐药机制及防治对策[J].中国呼吸与危重监护杂志,2002,1(2):71-75. 被引量:19
  • 2王东浩,王伟,王勇强,曹书华.重症监护病房获得性细菌感染临床调查[J].中华医院感染学杂志,2004,14(2):151-153. 被引量:127
  • 3戚其学,王春雷,李艳玲.169例非发酵革兰阴性杆菌所致院内获得性肺炎的危险因素及耐药性分析[J].中国血液流变学杂志,2007,17(2):290-292. 被引量:19
  • 4McGowan JE Jr. Resistance in nonfermenting gram-negative bacteria:multidrug resistance to the maximum. Am J Med, 2006, 119 : S29 -S36.
  • 5Quinn JP. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin Infect Dis, 1998,27 : S117-S124.
  • 6Tenover FC. Novel and emerging mechanisms of antimicrobial resistance in nosoeomial pathogens. Am J Med, 1991,91 : 76 S-81 S.
  • 7Smith SM, Eng RK, Teeson-Tumany F. Ciprofloxaein therapy for methieillin-resistant Staphylococcus aureus infections or colonizations. Antimicrob Agents Chemother,1989,33:181-184.
  • 8Du B, Chen D, Liu D, et al. Restriction of third-generation eephalosporin use decreases infection-related mortality. Crit Care Med,2003,31:1088-1093.
  • 9Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-laetamases at a Massachusetts chronic-care facility. Antimierob Agents Chemother, 1990,34:2193-2199.
  • 10Wallace MR, Johnson AP, Daniel M, et al. Sequential emergence of multi-resistant Klebsiella pneumoniae in Bahrain. J Hosp Infect, 1995,31:247-252.

共引文献180

同被引文献90

  • 1丘仲柳,曾凤群,赖天寿,谭柏松.2013年我院痰培养鲍氏不动杆菌的耐药性分析[J].医学信息(医学与计算机应用),2014,0(23):280-281. 被引量:1
  • 2卫生部卫生法制与监督司.消毒技术规范[S].[S].北京中华人民共和国卫生部,2002..
  • 3Gifford B,Tucci J,Mcllroy SJ,et al.Isolation and characterization of two plasmids in a clinical Acinetobacter nosocomialis strain[J].BMC Re- search Notes,2014,7(1):732-736.
  • 4Peleg AY,Seifert H,Paterson DL.Aeinetobacter baumannii:emergence of a suceessful pathogen[J].Clin Microhiol Rev,2008,21:538-582.
  • 5I Perez F, Hujer AM, Hujer KM, et al. Global challenge of muhidrug-re- sistant Aclnetobacter bhumannil [J].Antimicrob AgentsChemother, 2007,51:3471-3484.
  • 6Mera RM,Miller LA,Amfine-Madsen H,et al.Acinetobaeter baumannii 2002-2008:increase of carbapenem-associated multiclass resistance in the United States[J].Microb Drug Resist,2010,16(3):209-215.
  • 7Garnacho-Montero J,Amaya-Villar R.Multiresistant Acinetobacter baumannff infections: epidemiology and management. Curt Opin In- feet Dis, 2010,23(4):332-339.
  • 8Clinical and Laboratory Standards Institute. Performance stand- ards for antimicrobial susceptibility testing: twenty-third infor- mational supplement [ S ]. Wayne, PA: Clinical Laboratory Standards,2013:1 - 199.
  • 9Morgan D J, Rogawski E, Thorn KA, et al. Transfer of multi- drug-resistant bacteria to heahhcare workers' gloves and gowns after patient contact increases with environmental con- tamination[J]. Crit Care Med,2012,dO(4) :1 045 -1 051.
  • 10McGrath EJ, Chopra T, Abdel-Haq N, et al. An outbreak of carbapenem-resistant Acinetobacter baumannii infection in a neonatal intensive care unit:investigation and control [ J ]. Infect Control and Hosp Epidemiol,2011,32 ( I ) : 34 - 41.

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部